Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events

Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

(2013) A. F. Schott et al.   CLINICAL CANCER RESEARCH

CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy

(2013) Rosa Nadal et al.   INTERNATIONAL JOURNAL OF CANCER

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer

(2013) Suresh Kumar Swaminathan et al.   JOURNAL OF CONTROLLED RELEASE

Breast cancer as a systemic disease: a view of metastasis

(2013) A. J. Redig et al.   JOURNAL OF INTERNAL MEDICINE

Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype

(2012) Hoiseon Jeong et al.   HISTOPATHOLOGY

Isolation and characterization of calcium sensing receptor null cells: A highly malignant and drug resistant phenotype of colon cancer

(2012) Navneet Singh et al.   INTERNATIONAL JOURNAL OF CANCER

Biomarkers for the clinical management of breast cancer: International perspective

(2012) Neill Patani et al.   INTERNATIONAL JOURNAL OF CANCER

Classical and desmosomal cadherins at a glance

(2012) M. Saito et al.   JOURNAL OF CELL SCIENCE

CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer

(2012) Naoki Aomatsu et al.   PLoS One

Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression

(2012) Christian J. Gröger et al.   PLoS One

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients

(2011) Johanna G. H. van Nes et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma

(2011) Po Zhao et al.   CANCER SCIENCE

Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk

(2011) Solange Torchia Carvalho et al.   Clinics

Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

(2011) A. J. Armstrong et al.   MOLECULAR CANCER RESEARCH

Is N-Cadherin Expression Important in Ductal Carcinoma?

(2011) Judy A. King et al.   SOUTHERN MEDICAL JOURNAL

Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer

(2010) Chad J. Creighton et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy

(2010) C.-C. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

(2008) D. Sarrio et al.   CANCER RESEARCH

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

(2008) Alysha K. Croker et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control

(2008) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute

Cadherins in development and cancer

(2008) Marc P. Stemmler   Molecular BioSystems